Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jul 14, 2026 0

For millions worldwide, the diagnosis of actinic keratosis (AK) marks the beginning of a challenging journey to prevent skin cancer.…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Develop Breakthrough Reversible Nonhormonal Male Contraceptive Method Targeting Meiosis

Dwi Wanna Jul 5, 2026 0

In a significant advancement for reproductive medicine, scientists at Cornell University have identified a viable pathway toward a safe, reversible,…

Read More
Pharmaceutical R&D

Bocunebart’s PACAP-Targeting Mechanism Positions it as a Potential First-in-Class Therapy in a Thin Pipeline of Novel Late-Stage Candidates

Teuku Ryan Jul 2, 2026 0

New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 24, 2026 0

For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…

Read More
Molecular & Cell Biology

DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research

Angie Faith Jun 19, 2026 0

One of the most significant hurdles in unraveling the complexities of aging and a spectrum of diseases lies in the…

Read More
Pharmaceutical R&D

Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP

Teuku Ryan Jun 17, 2026 0

Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 16, 2026 0

Rubedo Life Sciences, an AI-driven biotech startup focused on longevity, has announced positive preliminary results from its Phase 1b/2a study…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis

Dwi Wanna Jun 6, 2026 0

In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna Jun 5, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 2, 2026 0

For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…

Read More

Posts pagination

1 2 3
Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across GenerationsScience News: A Century of Empowering Public Understanding of ScienceAI Isn’t Coming For Your Job: Automation IsFrom Single Cell to Complex Consciousness Researchers Unveil How Lineage Based Organization Drives Brain Development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ